Your browser is no longer supported. Please, upgrade your browser.
Settings
ARWR [NASD]
Arrowhead Research Corp.
Index- P/E- EPS (ttm)-1.31 Insider Own2.30% Shs Outstand54.79M Perf Week-12.69%
Market Cap369.28M Forward P/E- EPS next Y-1.25 Insider Trans0.10% Shs Float53.58M Perf Month-14.58%
Income-70.60M PEG- EPS next Q-0.37 Inst Own67.20% Short Float27.07% Perf Quarter7.32%
Sales0.30M P/S1230.95 EPS this Y3.80% Inst Trans-3.65% Short Ratio6.61 Perf Half Y-57.04%
Book/sh2.67 P/B2.52 EPS next Y15.00% ROA-43.70% Target Price14.50 Perf Year-58.80%
Cash/sh2.33 P/C2.90 EPS next 5Y7.33% ROE-47.00% 52W Range4.95 - 18.87 Perf YTD-8.67%
Dividend- P/FCF- EPS past 5Y21.70% ROI-31.80% 52W High-63.33% Beta2.17
Dividend %- Quick Ratio11.50 Sales past 5Y-44.50% Gross Margin- 52W Low39.80% ATR0.42
Employees81 Current Ratio11.50 Sales Q/Q290.30% Oper. Margin- RSI (14)43.41 Volatility6.34% 5.72%
OptionableYes Debt/Eq0.01 EPS Q/Q-64.00% Profit Margin- Rel Volume0.53 Prev Close6.74
ShortableYes LT Debt/Eq0.00 EarningsFeb 09 AMC Payout- Avg Volume2.19M Price6.92
Recom2.30 SMA20-6.59% SMA50-1.78% SMA200-27.91% Volume366,622 Change2.67%
Oct-09-14Downgrade RBC Capital Mkts Outperform → Sector Perform $35 → $9
Mar-05-14Initiated RBC Capital Mkts Outperform $35
Mar-05-14Initiated Deutsche Bank Buy $45
Feb-26-13Initiated Dawson James Buy $4
Mar-06-15 09:00AM  ARWR: Arrowhead Acquires Novartis RNAi Research and Development Portfolio Zacks Small Cap Research
Mar-05-15 12:54PM  Arrowhead Research Soars After Acquiring Novartis' RNAi Portfolio Benzinga +5.73%
07:34AM  Arrowhead buys Novartis' RNAi portfolio Reuters
07:30AM  Arrowhead Acquires Novartis RNAi Research and Development Portfolio Business Wire
Mar-04-15 07:30AM  Arrowhead to Present at 2015 Barclays Global Healthcare Conference Business Wire
Feb-26-15 07:04PM  Lightning Round: This is back in renaissance mode at CNBC
Feb-23-15 07:30AM  Arrowhead Begins Phase 1 Trial of ARC-AAT for Treatment of Liver Disease Associated with Alpha-1 Antitrypsin Deficiency Business Wire +6.10%
Feb-17-15 04:01PM  Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference Business Wire +5.02%
01:20PM  4 Biotech Stocks Under $10 to Trade for Breakouts: Sophiris, Atossa and More at TheStreet
Feb-14-15 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
Feb-11-15 07:09PM  10-Q for Arrowhead Research Corp. Company Spotlight
09:00AM  ARWR: Arrowhead Reports Fiscal 1Q15 Financial Results Zacks Small Cap Research
Feb-10-15 07:09AM  The News That Should Move Arrowhead Research Today Benzinga
Feb-09-15 04:30PM  Arrowhead Research Corp Earnings Call scheduled for 4:30 pm ET today CCBN
04:12PM  Arrowhead Research reports 1Q loss AP
04:06PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:01PM  Arrowhead Reports Fiscal 2015 First Quarter Financial Results Business Wire
07:07AM  Q1 2015 Arrowhead Research Corp Earnings Release - After Market Close CCBN
Feb-02-15 04:01PM  Arrowhead to Report Fiscal 2015 First Quarter Financial Results Business Wire
Jan-26-15 11:47AM  Arrowhead Research Corp (ARWR): Bridger Management Builds 5.5% Passive Stake at Insider Monkey +5.29%
Jan-14-15 02:58PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Arrowhead Research Corporation (ARWR) on Behalf of Shareholders PR Newswire +6.17%
Jan-12-15 12:55PM  Mid-Day Market Update: Foundation Medicine Shares Jump Following Deal With Roche; Crude Oil Slides Over 4% Benzinga -23.84%
10:16AM  Arrowhead Research (ARWR) Stock Plummets Today After FDA Partial Clinical Hold at TheStreet
09:13AM  Arrowhead Research Tumbles 20% Following FDA News Benzinga
08:18AM  FDA Informs Arrowhead of Partial Clinical Hold for Hepatitis B Drug at The Wall Street Journal
07:41AM  FDA asks Arrowhead to cut Hep B drug dosage in mid-stage trial Reuters
06:59AM  Arrowhead Provides Update on IND for ARC-520 Phase 2b Study Business Wire
Dec-31-14 09:41AM  Biotech Stocks Make Big Moves In Final Days Of 2014 Benzinga
Dec-29-14 07:30AM  CORRECTING and REPLACING Arrowhead Appoints Patrick OBrien as General Counsel Business Wire
Dec-15-14 07:30AM  Arrowhead Files IND for RNAi Therapeutic ARC-520 to Begin Phase 2b Multiple-Dose Studies in Chronic Hepatitis B Patients Business Wire -5.38%
Dec-05-14 10:00PM  ARROWHEAD 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Arrowhead Research Corp. -- ARWR GlobeNewswire +14.60%
02:40PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Arrowhead Research Corporation of Class Action Lawsuit and Upcoming Deadline -- ARWR GlobeNewswire
Dec-04-14 04:53PM  Arrowhead Appoints Patrick OBrien as General Counsel Business Wire -6.54%
Dec-03-14 10:22AM  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Arrowhead Research Corp. and Lead Plaintiff Deadline of December 9, 2014 PR Newswire
Dec-01-14 03:34PM  INVESTOR ALERT: Class Action Lawsuit Against Arrowhead Research Corporation Announced by Law Offices of Howard G. Smith Business Wire -7.39%
11:44AM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR PR Newswire
Nov-28-14 10:00PM  ARROWHEAD RESEARCH CORP. SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Arrowhead Research Corp. Business Wire
Nov-27-14 07:07PM  10-K for Arrowhead Research Corp. Company Spotlight
Nov-26-14 12:32PM  INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Arrowhead Research Corporation Business Wire
Nov-25-14 04:01PM  Arrowhead Reports Fiscal 2014 Year End Financial Results Business Wire -5.19%
03:57PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
07:07AM  Q4 2014 Arrowhead Research Corp Earnings Release - After Market Close CCBN
Nov-24-14 10:00PM  EQUITY ALERT: Rosen Law Firm Reminds Arrowhead Research Corp. Investors of Important December 9, 2014 Deadline in Class Action Filed by Firm - ARWR GlobeNewswire
03:36PM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 Business Wire
Nov-21-14 08:32PM  SHAREHOLDER ALERT: Investigation on Behalf of Arrowhead Research Corporation Investors Announced by Law Offices of Howard G. Smith Business Wire
04:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Arrowhead Research Corporation and Certain Officers - ARWR Marketwired
Nov-19-14 09:52PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Arrowhead Research Corp. To Contact Brower Piven Before The December 9, 2014 Lead Plaintiff Deadline In Class Action Lawsuit Business Wire -6.72%
Nov-18-14 04:01PM  Arrowhead to Report Fiscal 2014 Fourth Quarter and Year End Financial Results Business Wire
07:30AM  Arrowhead Files for Regulatory Permission to Begin Phase 1 Trial of RNAi Therapeutic ARC-AAT Business Wire
Nov-16-14 09:08PM  Arrowhead Research seeks to reassure antsy investors at Los Angeles Times
Nov-14-14 10:05PM  Important Reminder to Shareholders of Arrowhead Research Corporation of Upcoming Lead Plaintiff Deadline on December 9, 2014 GlobeNewswire
01:07PM  Arrowhead to Present at Upcoming Conferences Business Wire
Nov-12-14 12:29PM  ARWR INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR GlobeNewswire
Nov-10-14 06:55PM  Arrowhead CEO: We feel 'great' about the drug at CNBC
05:50PM  Big pharma's liver battle CNBC
03:56PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Arrowhead Research Corporation Marketwired
01:11PM  Hepatitis B next great challenge: Arrowhead CNBC
09:15AM  Arrowhead Presents Data on ARC-520 and ARC-AAT at AASLD The Liver MeetingĀ® 2014 Business Wire
Nov-07-14 03:18PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Arrowhead Research Corporation and Certain Officers - ARWR PR Newswire
Nov-06-14 12:32PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Arrowhead Research Corp. to Contact Brower Piven Before the December 9, 2014 Lead Plaintiff Deadline in Class Action Lawsuit --- A GlobeNewswire
Nov-04-14 08:30AM  Hagens Berman Announces the Filing of a Class Action Lawsuit Against Arrowhead Research Corporation, Inc. (NASDAQ: ARWR) GlobeNewswire
Nov-03-14 09:17AM  Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Arrowhead Research Corp. GlobeNewswire
Oct-31-14 08:38PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Arrowhead Research Corp. (ARWR) to Contact the Firm GlobeNewswire
Oct-27-14 04:49PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR Marketwired
09:11AM  Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
07:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Arrowhead Research Corporation of Class Action Lawsuit and Upcoming Deadline -- ARWR GlobeNewswire
Oct-24-14 03:22PM  EQUITY ALERT: Rosen Law Firm Reminds Arrowhead Research Corp. Investors of Important Deadline in Class Action Filed by Firm - ARWR GlobeNewswire
Oct-23-14 10:03AM  Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against Arrowhead Research Corporation -- ARWR GlobeNewswire
Oct-22-14 03:52PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Arrowhead Research Corp. To Contact Brower Piven Before The December 9, 2014 Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Oct-20-14 12:40PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR GlobeNewswire
Oct-17-14 11:49AM  ARROWHEAD RESEARCH CORP. SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Arrowhead Research Corp. GlobeNewswire -8.12%
09:41AM  5 Stocks Under $10 Set to Soar at TheStreet
Oct-15-14 10:18PM  Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Has Been Filed in the Central District of California Against Arrowhead Research Corporation -- ARWR GlobeNewswire +10.03%
05:23PM  Lifshitz & Miller Law Firm Announces Investigation of Apco Oil & Gas International Inc., Arrowhead Research Corporation, Auxilium Pharmaceuticals, Inc., EveryWare Global, Inc., and Gentiva Health Services, Inc. PR Newswire
04:10PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Arrowhead Research Corp. to Contact Brower Piven Before the December 9, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- AR GlobeNewswire
04:00PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Arrowhead Research Corp. (ARWR) To Contact The Firm Marketwired
11:22AM  Arrowhead Research Corp. Stockholders Who Suffered Losses in Excess of $100,000 Encouraged to Contact Securities Law Firm about Investigation PR Newswire
Oct-14-14 06:36PM  SHAREHOLDER ALERT: Class Action Lawsuit Against Arrowhead Research Corporation Filed By Glancy Binkow & Goldberg LLP Business Wire
12:45PM  Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Arrowhead Research Corporation PR Newswire
11:29AM  Arrowhead Research Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire
Oct-13-14 06:38PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Arrowhead Research Corporation and Certain Officers -- ARWR GlobeNewswire -5.34%
06:13PM  Robbins Arroyo LLP: Arrowhead Research Corporation (ARWR) Misled Shareholders According to a Recently Filed Class Action GlobeNewswire
04:00PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Arrowhead Research Corp. (ARWR) To Contact The Firm PR Newswire
11:14AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 Business Wire
Oct-10-14 05:25PM  EQUITY ALERT: The Rosen Law Firm Files Securities Fraud Class Action Against Arrowhead Research Corp. -- ARWR GlobeNewswire -7.95%
06:05AM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Oct-09-14 12:15PM  ARWR: Efficacy of ARC-520 Phase IIa not as Strong as Expected, But the Program Is still Viable Zacks Small Cap Research
11:37AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arrowhead Research Corp. - ARWR PR Newswire
08:30AM  Arrowhead Issues Open Letter to Shareholders Business Wire
07:54AM  ARROWHEAD SHAREHOLDER ALERT -- National Securities Law Firm Announces Investigation Of Arrowhead For Potential Violations Of Federal Securities Laws. Encourages Shareholders To Contact Law Firm For More Information. PR Newswire
06:38AM  Arrowhead Research downgraded by RBC Capital Mkts Briefing.com
01:13AM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Arrowhead Research Corp. - ARWR Business Wire
Oct-08-14 05:50PM  [video] Arrowhead oversold: Analyst at CNBC -43.80%
04:47PM  Fed to the rescueagain! Yahoo Finance Blogs
03:52PM  Blame Arrowhead Management Entirely for Today's Epic Collapse at TheStreet
02:32PM  Arrowhead Research Corp Hammered On Drug News; Deutsche Bank Lowers Price Target Benzinga
01:49PM  Midday Losers From October 8 - Arrowhead Research Corp, A10 Networks Inc. And More Benzinga
01:36PM  Merck, Bristol, Arrowhead Prep Hepatitis Studies at Investor's Business Daily
10:38AM  Arrowhead Research Sinks on Disappointing Hepatitis B Drug Data at TheStreet
10:00AM  Arrowhead to Present ARC-520 Phase 2a Data in Late-Breaking Session at AASLD Liver MeetingĀ® 2014 Business Wire
Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company's principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chronic hepatitis B virus infection; and ARC-AAT, a novel unlocked nucleobase analog containing RNAi-based therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency. Its platform technology include Dynamic Polyconjugate platform, an RNAi delivery system that addresses multiple organ systems and cell types. The company is also involved in the development of Adipotide, which is in phase I clinical trial for the treatment of obesity and metabolic disorders; and CRLX-101 that is in phase II clinical trial to treat various cancer types, including relapsed renal cell carcinoma, relapsed ovarian cancer, and non-metastatic rectal cancer. It has research collaboration and license agreement with Shire AG to develop and commercialize targeted peptide-drug conjugates. The company was formerly known as InterActive Group, Inc. Arrowhead Research Corporation was incorporated in 1989 and is headquartered in Pasadena, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lewis David L.Chief Scientific OfficerJan 05Option Exercise2.0115,00030,15015,000Jan 07 05:50 PM
Lewis David L.Chief Scientific OfficerJan 05Sale8.0115,000120,1040Jan 07 05:50 PM
Anzalone Christopher RichardPresident and CEOOct 15Buy6.3216,000101,120260,173Oct 15 05:31 PM
GIVEN DOUGLAS BDirectorSep 26Option Exercise2.192,0004,38022,000Sep 30 05:58 PM
GIVEN DOUGLAS BDirectorSep 26Sale15.242,00030,48020,000Sep 30 05:58 PM
GIVEN DOUGLAS BDirectorAug 15Option Exercise2.015,00010,05025,000Aug 19 05:15 PM
Myszkowski Kenneth AllenCFOAug 15Option Exercise6.3240,000252,850111,500Aug 19 05:15 PM
Myszkowski Kenneth AllenCFOAug 15Sale14.0240,000560,86071,500Aug 19 05:15 PM
GIVEN DOUGLAS BDirectorAug 15Sale13.905,00069,50120,000Aug 19 05:15 PM
McKenney CharlesDirectorJun 09Option Exercise2.3922,00052,48039,220Jun 10 09:28 PM
McKenney CharlesDirectorJun 09Sale14.3222,000315,00517,220Jun 10 09:28 PM